AZTA - Azenta, Inc. Stock Price, Fair Value and News

50.87USD-0.47 (-0.92%)Delayed

Market Summary

USD50.87-0.47

Delayed

-0.92%

AZTA Alerts

Big fall in earnings (Y/Y)

Losses in recent quarter

AZTA Stock Price

View Fullscreen

AZTA RSI Chart

AZTA Valuation

Market Cap

2.7B

Price/Earnings (Trailing)

-18.2

Price/Sales (Trailing)

4.21

EV/EBITDA

-31.98

Price/Free Cashflow

49.9

AZTA Price/Sales (Trailing)

AZTA Profitability

Operating Margin

26.52%

EBT Margin

-24.91%

Return on Equity

-6.78%

Return on Assets

-5.88%

Free Cashflow Yield

AZTA Fundamentals

AZTA Revenue

Revenue (TTM)

651.8M

Rev. Growth (Yr)

7.23%

Rev. Growth (Qtr)

3.12%

AZTA Earnings

Earnings (TTM)

-150.7M

Earnings Growth (Yr)

-2.7K%

Earnings Growth (Qtr)

-770.52%

Breaking Down AZTA Revenue

Last 7 days

-1.4%

Last 30 days

-0.6%

Last 90 days

-20.7%

Trailing 12 Months

19.1%

How does AZTA drawdown profile look like?

AZTA Financial Health

Current Ratio

5.86

Debt/Equity

0.02

Debt/Cashflow

1.84

AZTA Investor Care

Dividend Yield

0.19%

Dividend/Share (TTM)

0.1

Buy Backs (1Y)

17.26%

Diluted EPS (TTM)

-2.74

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	651.8M	0	0	0
2023	597.1M	630.3M	665.1M	641.0M
2022	551.2M	554.9M	555.5M	594.2M
2021	449.2M	485.0M	513.7M	535.2M
2020	361.4M	374.9M	388.5M	415.0M
2019	709.8M	741.3M	334.2M	347.8M
2018	497.8M	488.4M	631.6M	668.3M
2017	508.1M	542.2M	527.5M	510.1M
2016	545.9M	548.5M	434.0M	474.0M
2015	501.9M	529.5M	552.7M	549.9M
2014	461.2M	467.8M	482.8M	488.5M
2013	436.9M	407.3M	425.7M	444.7M
2012	576.7M	531.0M	489.0M	466.8M
2011	247.9M	75.3M	688.1M	630.0M
2010	0	38.5M	593.0M	420.4M
2009	0	0	218.7M	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Azenta, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 01, 2024	joseph jason	back to issuer	-60,150	60.15	-1,000	svp, general counsel, secy.
Mar 08, 2024	joseph jason	back to issuer	-270,000	67.5	-4,000	svp, general counsel, secy.
Mar 07, 2024	joseph jason	back to issuer	-586,010	65.1122	-9,000	svp, general counsel, secy.
Feb 12, 2024	davis robyn c	acquired	162,517	65.93	2,465	-
Feb 12, 2024	mclaughlin erica	acquired	162,517	65.93	2,465	-
Feb 12, 2024	casal frank	acquired	237,546	65.93	3,603	-
Feb 12, 2024	hirsch didier	acquired	162,517	65.93	2,465	-
Feb 12, 2024	madaus martin d	acquired	162,517	65.93	2,465	-
Feb 12, 2024	bousa edward peter	sold	-162,517	65.93	-2,465	-
Feb 12, 2024	rosenblatt michael	acquired	162,517	65.93	2,465	-

Which funds bought or sold AZTA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	Redwood Investment Management, LLC	new	-	1,497,000	1,497,000	0.14%
May 16, 2024	LEVIN CAPITAL STRATEGIES, L.P.	unchanged	-	-31,853	395,075	0.04%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-16.36	-894,227	3,062,770	-%
May 16, 2024	COMERICA BANK	reduced	-5.84	-1,243,210	8,423,440	0.04%
May 16, 2024	Beacon Capital Management, LLC	new	-	904	904	-%
May 16, 2024	FSA Wealth Management LLC	unchanged	-	-972	6,028	-%
May 16, 2024	Colony Group, LLC	added	25.78	105,000	742,000	0.01%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-91.54	-50,880,900	4,321,900	-%
May 15, 2024	Cetera Advisor Networks LLC	reduced	-0.33	-50,225	596,290	-%
May 15, 2024	PALISADE CAPITAL MANAGEMENT, LP	added	11.34	1,115,300	37,856,900	1.00%

Are Funds Buying or Selling AZTA?

Are funds buying AZTA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AZTA

No. of Funds

Unveiling Azenta, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	kayne anderson rudnick investment management llc	8.30%	4,623,311	SC 13G/A
Feb 13, 2024	vanguard group inc	10.14%	5,650,051	SC 13G/A
Jan 24, 2024	blackrock inc.	9.8%	5,462,777	SC 13G/A
Nov 15, 2023	politan capital management lp	7.92%	4,578,003	SC 13D/A
Nov 01, 2023	politan capital management lp	7.61%	4,578,003	SC 13D/A
Sep 14, 2023	politan capital management lp	6.87%	4,133,807	SC 13D
Feb 14, 2023	kayne anderson rudnick investment management llc	6.43%	4,437,157	SC 13G/A
Feb 09, 2023	william blair investment management, llc	2.6%	1,827,418	SC 13G/A
Jan 10, 2023	vanguard group inc	10.42%	7,194,160	SC 13G/A
Jan 06, 2023	blackrock inc.	10.4%	7,215,416	SC 13G/A

Recent SEC filings of Azenta, Inc.

View All Filings

Date Filed	Form Type	Document
May 09, 2024	10-Q	Quarterly Report
May 09, 2024	8-K	Current Report
May 08, 2024	8-K	Current Report
Apr 02, 2024	4	Insider Trading
Apr 01, 2024	144	Notice of Insider Sale Intent
Mar 14, 2024	8-K	Current Report
Mar 11, 2024	4	Insider Trading
Mar 08, 2024	144	Notice of Insider Sale Intent
Mar 07, 2024	144	Notice of Insider Sale Intent
Feb 14, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Azenta, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.13%	32.26%	-0.09	0.28	5.77%	8.23%

Azenta, Inc. News

Latest updates

Azenta, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	3.1%	159	154	172	166	148	178	138	133	146	140	137	129	130	118	108	93.00	95.00	92.00	148	204	198
Gross Profit	3.0%	63.00	62.00	68.00	68.00	53.00	74.00	58.00	60.00	71.00	67.00	66.00	62.00	58.00	57.00	53.00	39.00	42.00	39.00	-101	84.00	81.00
Operating Expenses	138.5%	210	88.00	85.00	84.00	66.00	102	73.00	65.00	76.00	67.00	87.00	63.00	67.00	57.00	-14.97	74.00	76.00	74.00	-18.64	67.00	67.00
S&GA Expenses	-0.3%	78.00	79.00	75.00	75.00	73.00	93.00	65.00	58.00	68.00	61.00	80.00	58.00	62.00	52.00	11.00	60.00	60.00	59.00	5.00	53.00	52.00
R&D Expenses	2.5%	9.00	8.00	9.00	9.00	9.00	8.00	8.00	7.00	7.00	6.00	7.00	5.00	5.00	5.00	-25.91	14.00	15.00	14.00	-24.17	14.00	14.00
EBITDA Margin	-229.4%	-0.11*	0.09*	0.09*	0.09*	0.08*	0.07*	0.09*	0.03*	0.03*	0.02*	0.04*	-0.05*	-	-	-	-	-	-	-	-	-
Interest Expenses	-	-	-	-	-	-	0.00	0.00	2.00	2.00	0.00	1.00	0.00	0.00	1.00	1.00	1.00	1.00	1.00	1.00	8.00	8.00
Income Taxes	-36.8%	-0.26	-0.19	-8.47	-1.20	-3.26	-4.60	2.00	7.00	-3.20	-4.70	-15.46	-0.80	-2.30	-1.55	-19.48	5.00	3.00	-2.96	-23.23	7.00	-1.03
Earnings Before Taxes	-761.8%	-137	-15.91	-5.64	-3.67	-5.25	-15.87	-3.40	0.00	-4.99	-1.82	-37.88	-2.60	-9.65	1.00	-81.91	19.00	13.00	10.00	-88.72	8.00	-3.86
EBT Margin	-424.0%	-0.25*	-0.05*	-0.05*	-0.04*	-0.04*	-0.04*	-0.02*	-0.08*	-0.09*	-0.10*	-0.10*	-0.19*	-	-	-	-	-	-	-	-	-
Net Income	-770.5%	-136	-15.72	3.00	-1.47	-4.93	-11.23	-20.76	-9.57	2,120	43.00	22.00	39.00	24.00	26.00	29.00	14.00	9.00	13.00	412	7.00	3.00
Net Income Margin	-690.7%	-0.23*	-0.03*	-0.02*	-0.06*	-0.08*	3.50*	3.84*	3.92*	4.03*	0.24*	0.22*	0.24*	-	-	-	-	-	-	-	-	-
Free Cashflow	-89.5%	2.00	15.00	30.00	9.00	-21.01	-39.86	-4.07	-435	-97.27	-2.79	9.00	36.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-9.2%	2,563	2,824	2,886	3,069	3,250	3,292	3,716	3,723	4,159	1,855	1,820	1,763	1,664	1,615	1,559	1,504	1,479	1,559	1,516	1,493	1,488
Current Assets	-13.9%	1,190	1,383	1,419	1,511	1,586	1,620	2,459	2,575	3,043	797	777	717	724	675	649	602	573	663	647	527	509
Cash Equivalents	-49.7%	353	703	679	733	667	608	658	1,474	1,936	215	227	270	320	264	251	257	242	335	257	157	137
Inventory	-3.8%	122	127	128	142	151	146	86.00	81.00	78.00	70.00	60.00	155	128	124	37.00	118	108	105	99.00	105	109
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	109	105	101	98.00	98.00
Goodwill	-14.9%	681	800	784	794	790	761	514	61.00	468	469	469	551	4.00	513	453	500	499	490	441	-	-
Liabilities	-10.5%	341	381	351	346	355	421	353	295	694	488	494	455	398	363	346	329	318	400	377	755	758
Current Liabilities	-13.8%	203	236	211	204	213	249	231	195	618	342	345	311	266	226	211	206	197	283	272	175	178
Long Term Debt	-	-	-	-	-	-	-	-	-	-	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	535	535
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	1.00	1.00	1.00	1.00	1.00	6.00	8.00
LT Debt, Non Current	-	-	-	-	-	-	-	-	-	-	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	535	535
Shareholder's Equity	-9.0%	2,223	2,444	2,535	2,724	2,895	2,871	3,363	3,428	3,465	1,367	1,325	1,308	1,266	1,252	1,214	1,175	1,161	1,159	1,139	738	730
Retained Earnings	-8.4%	1,488	1,625	1,641	1,638	1,639	1,644	1,655	1,676	1,686	-434	-470	-484	-516	-532	-551	-572	-578	-580	-586	-991	-991
Additional Paid-In Capital	-4.4%	999	1,045	1,156	1,323	1,495	1,490	1,992	1,990	1,987	1,978	1,976	1,966	1,960	1,950	1,943	1,937	1,933	1,926	1,922	1,915	1,910
Shares Outstanding	-2.0%	55.00	56.00	58.00	61.00	69.00	73.00	75.00	75.00	75.00	75.00	74.00	74.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	2,382	-	-	-	6,114	-	-	-	4,369	-	-	-	1,642	-	-	-	1,545

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-68.4%	8,356	26,431	39,912	16,748	-12,150	-27,020	9,634	-419,941	-71,357	15,618	27,112	44,803	34,212	43,730	51,799	26,124	-65,800	25,743	32,657	36,012	15,965
Share Based Compensation	75.0%	5,602	3,202	-715	3,995	3,991	2,105	-49.00	3,485	-661	7,891	7,179	6,086	7,481	6,710	3,969	3,724	4,214	4,410	4,941	5,455	5,250
Cashflow From Investing	-375.0%	-270,610	98,397	102,487	214,367	58,174	56,356	-374,478	31,867	1,826,626	-18,425	-17,515	-101,451	2,909	-30,292	-10,189	-8,515	-17,266	13,228	619,393	-5,872	-3,610
Cashflow From Financing	34.5%	-74,067	-113,153	-166,859	-172,085	-416	-504,720	1,751	-1,043	-55,790	-7,680	-4,458	-8,123	-5,168	-8,157	-5,443	-8,110	-5,368	-8,102	-500,961	-10,242	-11,380
Dividend Payments	-	-	-	-	-	-	-	-	-	-	7,494	7,438	7,432	7,432	7,424	7,386	7,380	7,378	7,369	7,237	7,229	7,221
Buy Backs	-34.6%	73,881	112,953	166,398	1,637	-	500,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

AZTA Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Revenue
Total revenue	$ 159,134	$ 148,401	$ 313,451	$ 326,767
Cost of revenue
Total cost of revenue	95,749	95,165	188,554	199,666
Gross profit	63,385	53,236	124,897	127,101
Operating expenses
Research and development	8,707	8,520	17,200	16,056
Selling, general and administrative	78,314	73,339	156,890	165,891
Impairment of goodwill and intangible assets	115,975		115,975
Contingent consideration - fair value adjustments		(17,145)		(17,145)
Restructuring charges	7,344	1,499	8,464	2,961
Total operating expenses	210,340	66,213	298,529	167,763
Operating loss	(146,955)	(12,977)	(173,632)	(40,662)
Other income
Interest income, net	9,565	10,394	19,646	21,059
Other income (expense), net	250	(2,668)	932	(1,523)
Loss before income taxes	(137,140)	(5,251)	(153,054)	(21,126)
Income tax benefit	(260)	(3,260)	(450)	(7,900)
Loss from continuing operations	(136,880)	(1,991)	(152,604)	(13,226)
Loss from discontinued operations, net of tax		(2,936)		(2,936)
Net loss	$ (136,880)	$ (4,927)	$ (152,604)	$ (16,162)
Basic net loss per share:
Loss from continuing operations (in dollars per share)	$ (2.47)	$ (0.03)	$ (2.72)	$ (0.19)
Loss from discontinued operations, net of tax (in dollars per share)		(0.04)		(0.04)
Basic net loss per share (in dollars per share)	(2.47)	(0.07)	(2.72)	(0.23)
Diluted net loss per share:
Loss from continuing operations (in dollars per share)	(2.47)	(0.03)	(2.72)	(0.19)
Loss from discontinued operations, net of tax (in dollars per share)		(0.04)		(0.04)
Diluted net loss per share (in dollars per share)	$ (2.47)	$ (0.07)	$ (2.72)	$ (0.23)
Weighted average shares used in computing net loss per share:
Basic (in shares)	55,440	69,111	56,078	70,858
Diluted (in shares)	55,440	69,111	56,078	70,858
Products
Revenue
Total revenue	$ 59,017	$ 51,917	$ 112,410	$ 137,715
Cost of revenue
Total cost of revenue	41,658	40,009	78,496	94,108
Services
Revenue
Total revenue	100,117	96,484	201,041	189,052
Cost of revenue
Total cost of revenue	$ 54,091	$ 55,156	$ 110,058	$ 105,558

AZTA Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Current assets
Cash and cash equivalents	$ 353,491	$ 678,910
Short-term marketable securities	468,220	338,873
Accounts receivable, net of allowance for expected credit losses ($6,844 and $8,057, respectively)	154,668	156,535
Inventories	122,351	128,198
Derivative asset	350	13,036
Short-term restricted cash	3,089	4,650
Prepaid expenses and other current assets	87,897	98,754
Total current assets	1,190,066	1,418,956
Property, plant and equipment, net	200,905	205,744
Long-term marketable securities	143,018	111,338
Long-term deferred tax assets	925	571
Operating lease right-of-use assets	69,662	66,580
Goodwill	681,140	784,339
Intangible assets, net	267,626	294,301
Other assets	10,155	3,891
Total assets	2,563,497	2,885,720
Current liabilities
Accounts payable	37,319	35,796
Deferred revenue	38,323	34,614
Accrued warranty and retrofit costs	9,745	10,223
Accrued compensation and benefits	27,985	33,911
Accrued customer deposits	21,772	17,707
Accrued income taxes payable	10,706	7,378
Short-term operating lease liability	10,802	9,499
Accrued expenses and other current liabilities	46,347	61,800
Total current liabilities	202,999	210,928
Long-term tax accruals	377	380
Long-term deferred tax liabilities	62,267	67,301
Long-term operating lease liabilities	63,374	60,436
Other long-term liabilities	11,609	12,175
Total liabilities	340,626	351,220
Stockholders' equity
Preferred stock, $0.01 par value - 1,000,000 shares authorized, no shares issued or outstanding
Common stock, $0.01 par value - 125,000,000 shares authorized, 68,464,925 shares issued and 54,614,041 shares outstanding at March 31, 2024, 71,294,247 shares issued and 57,832,378 shares outstanding at September 30, 2023	681	713
Additional paid-in capital	999,333	1,156,160
Accumulated other comprehensive loss	(41,728)	(62,426)
Treasury stock, at cost - 13,850,884 shares at March 31, 2024 and 13,461,869 shares at September 30, 2023	(223,820)	(200,956)
Retained earnings	1,488,405	1,641,009
Total stockholders' equity	2,222,871	2,534,500
Total liabilities and stockholders' equity	$ 2,563,497	$ 2,885,720

About Azenta, Inc.

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

CEO	Dr. Stephen S. Schwartz
WEBSITE	azenta.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	3500

Azenta, Inc. Frequently Asked Questions

What is the ticker symbol for Azenta, Inc.? What does AZTA stand for in stocks?

AZTA is the stock ticker symbol of Azenta, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Azenta, Inc. (AZTA)?

As of Fri May 17 2024, market cap of Azenta, Inc. is 2.74 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AZTA stock?

You can check AZTA's fair value in chart for subscribers.

What is the fair value of AZTA stock?

You can check AZTA's fair value in chart for subscribers. The fair value of Azenta, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Azenta, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AZTA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Azenta, Inc. a good stock to buy?

The fair value guage provides a quick view whether AZTA is over valued or under valued. Whether Azenta, Inc. is cheap or expensive depends on the assumptions which impact Azenta, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AZTA.

What is Azenta, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, AZTA's PE ratio (Price to Earnings) is -18.2 and Price to Sales (PS) ratio is 4.21. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AZTA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Azenta, Inc.'s stock?

In the past 10 years, Azenta, Inc. has provided 0.206 (multiply by 100 for percentage) rate of return.